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Time-to-completed-imaging, survival and
function in patients with spinal epidural
abscess: Description of a series of 34
patients, 2015–2018
Caroline King1* , Cameron Fisher2,3, Patrick C. M. Brown2, Kelsey C. Priest2,3, Mary Tanski2,4 and Peter Sullivan2,5
Abstract
Introduction: Spinal epidural abscess (SEA) is a rare and life-threatening infection with increasing incidence over
the past two decades. Delays in diagnosis can cause significant morbidity and mortality among patients.
Objective: The objective of this study was to describe trends in time-to-imaging and intervention, risk factors, and
outcomes among patients presenting to the emergency department with SEA at a single academic medical center
in Portland, Oregon.
Methods: This retrospective cohort study analyzed data from patients with new SEA diagnosis at a single hospital
from October 1, 2015 to April 1, 2018. We describe averages to time-to-imaging and interventions, and frequencies
of risk factors and outcomes among patients presenting to the emergency department with SEA.
Results: Of the 34 patients included, 7 (20%) died or were discharged with plegia during the study period. Those
who died or were discharged with plegia (n = 7) had shorter mean time-to-imaging order (20.8 h versus 29.2 h).
Patients with a history of intravenous drug use had a longer mean time-to-imaging order (30.2 h versus 23.7 h) as
compared to those without intravenous drug use. Patients who died or acquired plegia had longer times from
imaging completed to final imaging read (20.9 h versus 7.1 h), but shorter times from final imaging read to surgical
intervention among patients who received surgery (4.9 h versus 46.2 h). Further, only three (42.9%) of the seven
patients who died or acquired plegia presented with the three-symptom classic triad of fever, neurologic
symptoms, and neck or back pain.
Conclusions: SEA is a potentially deadly infection that requires prompt identification and treatment. This research
provides baseline data for potential quality improvement work at the study site. Future research should evaluate
multi-center approaches for identifying and intervening to treat SEA, particularly among patients with intravenous
drug use.
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Spinal epidural abscess (SEA) is a rare but life-
threatening infection; recent epidemiologic studies re-
port an increased incidence of SEA over the past two de-
cades [1, 2]. Explanations for this increase are
multifactorial and may include increased use of invasive
spinal procedures, improved sensitivity and availability
of diagnostic tools (e.g., magnetic resonance imaging),
population age, and the opioid-related overdose epi-
demic, specifically, an increase in intravenous drug use
(IVDU), which is a SEA risk factor [1, 2] . The com-
monly taught clinical triad for SEA is fever, neurologic
status changes, and back or neck pain; however, previous
research demonstrates that patients rarely present with
all three symptoms [3, 4] and 20% of patients with SEA
have no associated risk factors [1]. Thus, risk-factor-
based screening remains of limited clinical utility. Un-
surprisingly, SEA is frequently misdiagnosed or under-
diagnosed [3, 4], and when successfully diagnosed, a
delay to diagnosis is common.
These delays in SEA diagnosis may cause significant
morbidity and mortality among patients [3, 4]. Neuro-
logical outcomes depend on the symptom severity at
presentation and duration prior to diagnosis [4]. Mortal-
ity is also related to delayed recognition emphasizing the
importance for timely diagnosis [1, 3]. Little research on
interventions to reduce delays has been conducted to
date. This study sought to evaluate a cohort of patients
diagnosed with SEA at a single academic health center
in Portland, Oregon. Here, we describe trends in time-
to-imaging and intervention, risk factors, and outcomes
among people presenting to the emergency department
(ED) with SEA.
Methods
Study design and setting
This retrospective cohort analysis was completed at the
Oregon Health & Science University (OHSU) hospital in
Portland, Oregon. OHSU is a 550-bed teaching hospital,
Level-1 trauma Center, that is Oregon’s sole academic
health center. This case series includes OHSU patient
encounters between October 1, 2015 and April 1, 2018.
Participants
Patients were at least 18 years old at the time of ED
presentation and were diagnosed with a SEA during the
encounter (ICD-10 code G06.1). Patients who were
transferred to OHSU after receiving imaging at an out-
side hospital were excluded, as were patients who were
admitted directly to an inpatient floor at OHSU. This
allowed us to better capture how the emergency depart-
ment at our institution evaluated patients with suspected
SEA.
Variables
The primary variable of interest was time in hours from
diagnostic imaging order to the time that imaging was
completed. For patients with multiple visits to the hos-
pital prior to imaging, the earliest visit hour without a
72-h gap until or between subsequent visits was consid-
ered ED presentation time. Additional time intervals col-
lected and reported include: 1) time from ED
presentation to imaging order; 2) time from imaging
order to imaging complete; 3) time from imaging com-
pletion to imaging final with radiology reading; and 4)
time from final imaging read to surgical intervention.
The time at which the spinal abscess pathology cultures
were sent was a proxy for surgical intervention. We also
used the imaging order time that confirmed the spinal
epidural abscess for evaluation (versus, for example, a
CT that did not identify a SEA before an MRI was
completed).
At OHSU, treating physicians worked with surgical
and infectious disease specialists to make decisions re-
garding surgical versus medical intervention in treating
SEA. To report how often surgical versus medical inter-
ventions were pursued, we also identified the proportion
of patients who were treated surgically versus with anti-
biotics. For patients with suspected infection, the OHSU
emergency department protocol was to treat septic pa-
tients with broad-spectrum antibiotics; patients who
were clinically stable may wait for surgical biopsy or cul-
ture results before receiving antibiotic treatment.
Demographics
Collected demographics and covariates are reported in
Table 1. Variables reported were identified via chart ab-
straction or from administrative billing data. Data from
administrative data included age (years), sex (male/fe-
male), race (Black/Caucasian/Asian/American Indian or
Alaska Native/Other), insurance status (any Medicaid/
any Medicare/private insurance/no insurance), history of
alcohol use disorder (ICD-10 code F10.x; y/n), history of
HIV/AIDS (ICD-10 codes B20, Z21; y/n), history of Dia-
betes Mellitus (ICD-10 codes E11.x; y/n), history of
Chronic Kidney Disease (ICD-10 codes I12.x, I13.x,
N18.x; y/n), currently on dialysis (ICD-10 code Z99.2; y/
n), active malignancy (ICD-10 codes C00-C96; y/n), his-
tory of homelessness (ICD-10 code Z59.0; y/n), seen at
OHSU or elsewhere in previous 72 h (y/n), left against
medical advice within previous 72 h (y/n), and culture
results of abscess (staph aureus/methicillin resistant
staph aureus/Propionibacterium acnes/strep pyogenes/
aggregatibacter aphrophilus/no growth/no culture).
Data identified and abstracted from chart review in-
clude presence of a fever (temperature > 99.5) within
first 24 h of hospital contact (y/n), presence of
paresthesia, focal weakness or abnormal neurologic
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exam within first 24 h of hospital contact (y/n), presence
of neck or back pain in first 24 h of hospital contact (y/
n), history of injection drug use (y/n), and interval-based
times to imaging and surgical intervention. The number
of patients presenting with combinations of fever, back
or neck pain, and abnormal neurologic exam in the first
24 h are also reported; abnormal neurologic exam in-
cluded any abnormality listed in the neurologic and
motor exams in documented review of systems, and any
listed neurologic or motor deficit in the clinical sum-
mary. Demographic variables were determined in con-
sultation with treating teams and through a literature
review, which identified risk factors for mortality from
SEA, as well as for risk of recurrence [5, 6]. Finally, we
also report the type of imaging that first detected a
spinal epidural abscess (type of MRI versus CT).
Outcome
The primary outcome was a composite variable of plegia
at discharge or in-hospital death. Plegia was identified
using ICD-10 codes G81, G82, G83.1, G83.2, and G83.3
and verified via chart review by a reviewer blinded to
ICD-10 code information. This composite variable was
agreed upon by study team as a relevant study outcome
with implications for care delivery for SEA patients. For
patients who left the hospital and subsequently returned
within 72-h, the outcome was recorded from the last en-
counter with less than a 72-h gap between encounters.
Analysis
Because SEA is rare, we anticipated a low number of
cases at our institution meeting our inclusion criteria.
We describe our cohort of patients using measures of
Table 1 Demographics of patients diagnosed with spinal epidural abscess in a retrospective cohort study at Oregon Health &
Science University, 2015–2018
Plegia or death (n = 7) No plegia or death (n = 27)
Age 55.1 (16.2) 49.2 (15.5)
Sex
Female 3 (42.9) 10 (37.0)
Race
White 5 (71.4) 23(85.2)
African-American 0 2 (7.4)
Asian 1 (14.3) 0
American Indian/Alaska Native 0 0
Other/declined 1 (14.3) 2 (7.4)
Insured
Any Medicare 5 (71.4) 24 (88.9)
Any Medicaid 3 (42.9) 8 (29.6)
Private Insurance 1 (14.3) 2 (7.4)
No Insurance 0 1 (3.7)
Military Insurance 0 7 (25.9)
Fever in first 24 h 4 (57.1) 17 (63.0)
Back or neck pain in first 24 h 7 23 (85.2)
Paresthesia, focal weakness or abnormal neuro exam in first 24 h 6 (85.7) 18 (66.7)
Intravenous drug use 2 (28.6) 18 (66.7)
Alcohol use disorder 2 (28.6) 4 (14.8)
Seen by healthcare facility in 72 h prior to presentation 2 (28.6) 7 (25.9)
Left against medical advice in previous 72 h 1 (14.3) 1 (3.7)
HIV/AIDS 0 1 (3.7)
Homeless 1 (14.3) 7 (25.9)
Diabetes 3 6
On dialysis 0 1
Chronic Kidney Disease 1 2
Active malignancy 0 1
*values shown are n(%) or mean (SD)
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central tendency (means and medians) and frequencies
of variables collected, characterized by the dichotomous
outcome variable (plegia or death at discharge).
Consent and ethical considerations
This project was approved by OHSU’s Institutional Re-
view Board (IRB #00018422).
Results
Of the 34 patients included in the cohort, three died and
four were discharged with plegia (Fig. 1). Of those seven,
two had a history of IVDU (Table 1). All seven pre-
sented initially with back or neck pain within the first
24-h of ED contact; six (85.7%) had an abnormal neuro-
logic exam, and four (57.1%) had a fever greater than
99.5 degrees Fahrenheit (Table 2). Three (42.9%) of the
seven patients who died or acquired plegia presented
with the classic triad of fever, back or neck pain, and
neurologic changes. As described above, we included pa-
tients with surgical and non-surgical treatment plans for
SEA; of the 34 patients, 24 patients underwent surgical
intervention for SEA (70.6%).
Patients who died or acquired plegia had a mean time-
to-imaging order and time from imaging order to com-
pleted imaging shorter than those who survived without
plegia (20.8 h versus 29.2 h, and 11.5 h to 14.2 h, respect-
ively) (Table 3). Among people with a history of IVDU,
the mean time from ED presentation to imaging order
was longer (30.2 h versus 23.7 h) than those without a
history of IVDU. Patients who died or acquired plegia
had longer times from imaging completed to final im-
aging read (20.9 h versus 7.1 h), but shorter times from
final imaging read to surgical intervention among pa-
tients who received surgery (4.9 h versus 46.2 h).
Fig. 1 Participant enrollment flowchart
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All patients had diagnostic imaging completed that
identified their spinal epidural abscess (Table 4). The
most commonly ordered diagnostic images were MRI of
the lumbar spine with and without contrast (n = 7,
20.6%) and MRI of the total spine with and without con-
trast (n = 7, 20.6%). Four patients of 34 had their SEA
identified by CT (11.8%).
Of the 13 patients with positive cultures who used
intravenous drugs and received surgical intervention, 11
patient samples grew either staph aureus or methicillin-
resistant staph aureus, as expected (Table 5). The
remaining two patients’ cultures grew propionibactirum
acnes and aggregatibacter aphrophilus. Among the seven
patients with positive cultures without IVDU history,
five grew staph aureus, one grew methicillin resistant
staph aureus, and one grew strep pyogenes.
Discussion
The study objective was to describe averages in time-to-
imaging and intervention and frequencies of risk factors
and outcomes, among people with SEA. Of the 34 pa-
tients in our cohort, 7 (20%) died or were discharged
with plegia during the study period. Those who died or
were discharged with plegia (n = 7) had shorter mean
time-to-imaging order; patients with a history of IVDU
had a longer mean time-to-imaging order versus those
without IVDU.
Estimating 303,243 patient visits per year at OHSU
overall [7], in this time period we observed an incidence
of 1.12 per 10,000 visits for new SEA (excluding patients
with SEA diagnosed elsewhere that were transferred to
OHSU)). In our study, four patients were discharged
with plegia (11.8%) and three died in the hospital (8.8%).
Recent work cites plegia rates to be around 22% follow-
ing SEA, with mortality between 3 and 25% [8]. Our
rates of plegia and mortality among newly diagnosed pa-
tients were lower than published averages.
Among patients with SEA who developed plegia or
died, times from ED presentation to imaging order to
imaging complete, and from final imaging read to surgi-
cal intervention, were all shorter than for patients who
did not develop plegia or die. However, time from im-
aging completed to final imaging read were nearly 2.5
times longer for patients who died or developed plegia.
While this could suggest this is a meaningful interval to
address for patients screened for SEA, perhaps equally
important is the overall time from ED presentation to
surgical intervention for patients in both groups.
Among patients who died or developed plegia, the
average time from presentation to surgical intervention
was 58.1 h; for patents without plegia or death, the aver-
age time was nearly twice that, at 96.7 h. Recent research
has advocated for advancing patients to surgery more
quickly when suspicious for a SEA [9]. Better achieving
this may mean expediting evaluation and treatment for
patients with SEA; times to imaging and intervention
should be explored as potential quality measures.
Patients with a history of IVDU had longer wait times
than patients without a history of IVDU from the time
they presented to the ED to the time of imaging order.
This is an important finding that should be evaluated in
larger studies. The reasons for delayed care could be re-
lated to multifactorial and complex contributions related
to discrimination, stigma, and limited education on how
Table 2 Table of patients presenting with combinations of fever, back or neck pain, or abnormal neurologic exam in the first 24 h of
care for spinal epidural abscess, 2015–2018
Plegia or death (n = 7) No plegia or death (n = 27)
Fever only 4 (57.1) 17 (63.0)
Back or neck pain only 7 23 (85.2)
Abnormal neuro exam only 6 (85.7) 18 (66.7)
Fever and back/neck pain 4 (57.1) 16 (59.3)
Fever and abnormal neuro exam 3 (42.9) 11 (40.7)
Back/neck pain and abnormal neuro exam 6 (85.7) 14 (51.9)
Fever, back/neck pain and abnormal neuro exam 3 (42.9) 10 (37.0)
Table 3 Interval imaging times in hours for patients with spinal epidural abscess in a retrospective cohort study at Oregon Health &
Science University, 2015–2018
Time from: Plegia or death (n = 7) No plegia or death (n = 27)
ED presentation to imaging order 20.8 (37.0) 29.2 (44.9)
Imaging order to imaging completed 11.5 (8.6) 14.2 (23.3)
Imaging completed to final imaging read 20.9 (33.6) 7.1 (7.3)
Final imaging read to surgical intervention (n = 5 for plegia/died, n = 19 for survived) 4.9 (9.4) 46.2 (52.1)
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to care for patients with substance use disorders (e.g.,
clinical management of acute intoxication or withdrawal)
among ED providers. Some of the barriers to care for
persons with IVDU in the ED, particularly as they relate
to stigma, are described elsewhere [10–12].
Fewer than half of the patients who died or acquired
plegia presented with the classic triad of fever, back or
neck pain, and neurologic changes. This was unsurpris-
ing; though the classic triad for SEA exists, patients are
rarely documented presenting with all three symptoms
[3, 4]; one paper identified all three symptoms in only
8% of patients [13]. However, all seven patients who de-
veloped plegia or died presented initially with back or
neck pain. The prognostic value of back or neck pain
alone in supporting further work-up for SEA should be
examined in future work.
Most patients had an MRI ordered which diagnosed
their SEA; only four patients had CT scans completed
that identified their SEA. MRIs are the modality of
choice in diagnosing SEA, as they allow for better ex-
ploration of soft tissue and may be more sensitive at
identifying SEA [14]. Reviews highlight that CT should
only be ordered to diagnose SEA where MRI is
unavailable or contraindicated [15], but surgical teams
may prefer to have both MRI and CT at the time of sur-
gical intervention to better evaluate invasion into bony
spaces.
This paper was strengthened by the identification of
only new SEA cases within our health care system, thus
limiting cases to those truly new to healthcare providers.
This work also identifies a new, hard to capture variable
for consideration in the evaluation of care quality for pa-
tients with SEA: time from imaging to surgical interven-
tion. However, this paper was limited by the by the
available patient population because of the criteria for
cohort enrollment; specifically, our requirement that pa-
tients not receive outside imaging prior to transfer re-
duced our sample size, though it did allow us to
accurately report basic information about time-to-
imaging among this cohort. Further, around 40% of our
cohort did not have IVDU as a primary risk factor for
SEA. While we include some additional co-morbid con-
ditions including active malignancy, HIV, and diabetes,
we did not request the extraction of lab data (white cell
counts, erythrocyte sedimentation rate, and C-reactive
protein) or information about the extent or location of
Table 4 Type of imaging first detecting spinal epidural abscess among patients at Oregon Health & Science University, 2015–2018
Type of imaging Number of patients n = 34 (%)
CT abdomen and pelvis with contrast 1 (2.9%)
CT neck soft tissue with contrast 2 (5.9%)
CT spine total w contrast 1 (2.9%)
MRI spine cervical with and without contrast 2 (5.9%)
MRI spine lumbar without contrast 2 (5.9%)
MRI spine lumbar with and without contrast 7 (20.6%)
MRI spine thoracic lumbar with and without contrast 1 (2.9%)
MRI spine thoracic without contrast 3 (8.8%)
MRI spine thoracic with and without contrast 2 (5.9%)
MRI spine total with and without contrast 3 (8.8%)
MRI total spine without contrast 3 (8.8%)
MRI total spine with and without contrast 7 (20.6%)
Table 5 Culture results from patients with spinal epidural abscess with and without a history of intravenous drug use in a
retrospective cohort study at Oregon Health & Science University, 2015–2018
History of intravenous drug use (n = 20) No history of intravenous drug use (n = 14)
Aggregatibacter aphrophilus 1 (5.0) 0
Staphylococcus aureus 4 (20.0) 5 (35.7)
Methicillin-resistant Staphylococcus aureus 7 (35.0) 1 (7.1)
Propionibacterium acnes 1 (5.0) 0
Streptococcus pyogenes 0 1 (7.1)
No growth 2 (10.0) 1 (7.1)
No culture 6 (30.0) 4 (28.6)
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abscesses, which may have implications for time from
presentation to diagnosis. Further, we used ICD-10
codes to identify some co-morbid conditions and to cull
our initial sample of patients with SEA. It is likely that
some patients with conditions do not have appropriate
ICD-10 codes in their charts, and we may be missing co-
morbid conditions or cases of SEA. Finally, because the
study design did not have sufficient power for univariate
or multivariate analyses, confounding variables such as
patient comorbidities and severity of presenting illness
were not directly accounted for in reporting central ten-
dencies; thus, it is possible that the seven patients with
mortality and poor morbidity outcomes had shorter
mean time-to-imaging because they presented as “sicker”
than the other patients.
There are important implications from this work. Fu-
ture research should evaluate multi-center approaches
for identifying and intervening to treat SEA, particularly
among patients with IVDU, specifically to understand
what delays may exist for patients and how to decrease
those delays. Additional analyses should include evalua-
tions of time intervals from patient presentation through
intervention, though this information may be challen-
ging to obtain; this study obtained imaging information
through chart review versus automated data collection.
SEAs are serious infections causing significant morbidity
and mortality among a growing patient population in the
United States [1]. While there is consensus that time to
identification and intervention likely impact survival and
outcomes, limited research exists to evaluate potential
places for intervention to improve time to identification and
intervention among patients presenting to the ED with
SEA. We hope to build on this research by following for-
ward a cohort of patients with SEA at OHSU. Finally, the
authors of this paper plan work together with an interdis-
ciplinary team of providers to identify targets from this data
to reduce the overall wait times for imaging to identify SEA.
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